• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于显著功能表达识别慢性胰腺炎的miRNA-mRNA调控网络。

Identifying miRNA-mRNA regulation network of chronic pancreatitis based on the significant functional expression.

作者信息

Wang Dan, Xin Lei, Lin Jin-Huan, Liao Zhuan, Ji Jun-Tao, Du Ting-Ting, Jiang Fei, Li Zhao-Shen, Hu Liang-Hao

机构信息

Department of Gastroenterology Digestive Endoscopy Center, Changhai Hospital, the Second Military Medical University, Shanghai, China.

出版信息

Medicine (Baltimore). 2017 May;96(21):e6668. doi: 10.1097/MD.0000000000006668.

DOI:10.1097/MD.0000000000006668
PMID:28538367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5457847/
Abstract

BACKGROUND

The aim of this study was to explore the underlying molecular mechanism and potential molecular biomarkers of chronic pancreatitis (CP) and construct a miRNA-mRNA regulation network.

METHODS

To explore the involvement of miRNAs in CP, we downloaded the miRNA and mRNA expression profiles of CP patients and healthy controls and identified the differentially expressed miRNAs and genes. Functional analysis was conducted and significant pathways were utilized. Finally, the miRNA-mRNA regulation network of CP was constructed.

RESULTS

A total of 44 miRNA risk gene pathway relationships were identified, and a complex regulation network was constructed with 3 genes (ABL1, MYC, and ANAPC13) having the highest degree in affecting the network of CP. Importantly, 4 risk genes (NOTCH3, COX5A, THBS1, and KARS) and 1 risk miRNA (hsa-miR-324-5p) were identified with high prediction accuracy.

CONCLUSIONS

In conclusion, we analyzed miRNAs and mRNAs expression profiles in CP, 1 risk miRNA, and 4 risk genes were identified with high prediction accuracy as biomarkers of CP. Although further evaluation in clinical study is needed, our findings provide new insights into the pathogenesis of CP and may improve the diagnosis and therapy by identifying novel targets.

摘要

背景

本研究旨在探索慢性胰腺炎(CP)潜在的分子机制和分子生物标志物,并构建miRNA - mRNA调控网络。

方法

为探究miRNA在CP中的作用,我们下载了CP患者和健康对照的miRNA和mRNA表达谱,鉴定差异表达的miRNA和基因。进行功能分析并利用显著的通路。最后,构建CP的miRNA - mRNA调控网络。

结果

共鉴定出44个miRNA风险基因通路关系,构建了一个复杂的调控网络,其中3个基因(ABL1、MYC和ANAPC13)在影响CP网络方面具有最高的度数。重要的是,鉴定出4个风险基因(NOTCH3、COX5A、THBS1和KARS)和1个风险miRNA(hsa - miR - 324 - 5p),预测准确性高。

结论

总之,我们分析了CP中的miRNA和mRNA表达谱,鉴定出1个风险miRNA和4个风险基因,作为CP的生物标志物预测准确性高。尽管需要在临床研究中进一步评估,但我们的发现为CP的发病机制提供了新见解,并可能通过识别新靶点改善诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5457847/f6ba5af6d4ab/medi-96-e6668-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5457847/39e9f73ef15d/medi-96-e6668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5457847/527260c141ec/medi-96-e6668-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5457847/f6ba5af6d4ab/medi-96-e6668-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5457847/39e9f73ef15d/medi-96-e6668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5457847/527260c141ec/medi-96-e6668-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5457847/f6ba5af6d4ab/medi-96-e6668-g009.jpg

相似文献

1
Identifying miRNA-mRNA regulation network of chronic pancreatitis based on the significant functional expression.基于显著功能表达识别慢性胰腺炎的miRNA-mRNA调控网络。
Medicine (Baltimore). 2017 May;96(21):e6668. doi: 10.1097/MD.0000000000006668.
2
Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.通过整合转录组分析鉴定胰腺癌中的miRNA-mRNA相互作用
Eur Rev Med Pharmacol Sci. 2015;19(5):825-34.
3
Novel blood-based microRNA biomarker panel for early diagnosis of chronic pancreatitis.新型基于血液的 microRNA 生物标志物panel 用于慢性胰腺炎的早期诊断。
Sci Rep. 2017 Jan 11;7:40019. doi: 10.1038/srep40019.
4
Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.预测胰腺癌中TF-miRNA-mRNA和lncRNA-miRNA-mRNA两种调控机制的生物信息学方法。
Cell Biochem Biophys. 2014 Dec;70(3):1849-58. doi: 10.1007/s12013-014-0142-y.
5
Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.对喉鳞状细胞癌中lncRNAs、mRNAs和miRNAs的差异表达谱进行综合分析,以构建ceRNA网络并鉴定潜在生物标志物。
J Cell Biochem. 2019 Oct;120(10):17963-17974. doi: 10.1002/jcb.29063. Epub 2019 May 24.
6
Molecular Mechanism Exploration of Pancreatitis Based on miRNA Expression Profile.
Clin Lab. 2019 Mar 1;65(3). doi: 10.7754/Clin.Lab.2018.180807.
7
Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.鉴定参与 HBV 相关 HCC 发病机制的潜在 miRNA-mRNA 调控网络。
J Transl Med. 2019 Jan 3;17(1):7. doi: 10.1186/s12967-018-1761-7.
8
Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.鼻咽癌中miRNA/mRNA负调控对的鉴定
Med Sci Monit. 2016 Jun 28;22:2215-34. doi: 10.12659/msm.896047.
9
Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma by Integrated Microarray Analysis.通过综合微阵列分析鉴定肝细胞癌中潜在的功能性环状RNA-微小RNA-信使RNA调控网络
Med Sci Monit Basic Res. 2018 Apr 30;24:70-78. doi: 10.12659/MSMBR.909737.
10
Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.与结直肠癌进展密切相关的微小RNA及其基因靶点的计算分析
Microrna. 2019;8(1):68-75. doi: 10.2174/2211536607666180803100246.

引用本文的文献

1
microRNA-637/661 ameliorate hypoxic-induced pulmonary arterial hypertension by targeting TRIM29 signaling pathway.微小 RNA-637/661 通过靶向 TRIM29 信号通路改善低氧诱导的肺动脉高压。
Sci Rep. 2024 Nov 14;14(1):27971. doi: 10.1038/s41598-024-79769-2.
2
Candidate circulating microRNA biomarkers in dogs with chronic pancreatitis.犬慢性胰腺炎的候选循环 microRNA 生物标志物。
J Vet Intern Med. 2024 Mar-Apr;38(2):995-1004. doi: 10.1111/jvim.17009. Epub 2024 Feb 13.
3
Primer Exchange Reaction Coupled with DNA-Templated Silver Nanoclusters for Label-Free and Sensitive Detection of MicroRNA.

本文引用的文献

1
Novel blood-based microRNA biomarker panel for early diagnosis of chronic pancreatitis.新型基于血液的 microRNA 生物标志物panel 用于慢性胰腺炎的早期诊断。
Sci Rep. 2017 Jan 11;7:40019. doi: 10.1038/srep40019.
2
Bromodomain Inhibitors Correct Bioenergetic Deficiency Caused by Mitochondrial Disease Complex I Mutations.溴结构域抑制剂可纠正由线粒体疾病复合体I突变引起的生物能量缺陷。
Mol Cell. 2016 Oct 6;64(1):163-175. doi: 10.1016/j.molcel.2016.08.023. Epub 2016 Sep 22.
3
Redox-sensitive MAPK and Notch3 regulate fibroblast differentiation and activation: a dual role of ERK1/2.
引物交换反应耦合 DNA 模板银纳米簇用于 miRNA 的无标记和灵敏检测
Appl Biochem Biotechnol. 2023 Oct;195(10):6334-6344. doi: 10.1007/s12010-023-04420-1. Epub 2023 Mar 2.
4
5-FU-miR-15a Inhibits Activation of Pancreatic Stellate Cells by Reducing YAP1 and BCL-2 Levels In Vitro.5-FU 抑制 miR-15a 通过降低 YAP1 和 BCL-2 水平抑制胰腺星状细胞的活化。
Int J Mol Sci. 2023 Feb 16;24(4):3954. doi: 10.3390/ijms24043954.
5
The potential value of exosomes as adjuvants for novel biologic local anesthetics.外泌体作为新型生物局部麻醉剂佐剂的潜在价值。
Front Pharmacol. 2023 Jan 26;14:1112743. doi: 10.3389/fphar.2023.1112743. eCollection 2023.
6
The Role of MicroRNAs in Pancreatitis Development and Progression.微小 RNA 在胰腺炎发生和进展中的作用。
Int J Mol Sci. 2023 Jan 5;24(2):1057. doi: 10.3390/ijms24021057.
7
miR-23a-3p promotes the development of colon cancer by inhibiting the expression of NDRG4.微小RNA-23a-3p通过抑制NDRG4的表达促进结肠癌的发展。
Clin Transl Oncol. 2023 Apr;25(4):933-940. doi: 10.1007/s12094-022-02996-4. Epub 2022 Nov 14.
8
Systematic analyses of a novel circRNA-related miRNAs prognostic signature for Cervical Cancer.一种新型环状RNA相关微小RNA对宫颈癌预后的系统分析
Genet Mol Biol. 2022 Jun 24;45(2):e20210405. doi: 10.1590/1678-4685-GMB-2021-0405. eCollection 2022.
9
Construction of the miRNA-mRNA Regulatory Networks and Explore Their Role in the Development of Lung Squamous Cell Carcinoma.微小RNA-信使核糖核酸调控网络的构建及其在肺鳞状细胞癌发生发展中的作用探索
Front Mol Biosci. 2022 May 31;9:888020. doi: 10.3389/fmolb.2022.888020. eCollection 2022.
10
Differential expressions of miR-223, miR-424, miR-145, miR-200c, miR-139 in experimental rat chronic pancreatitis model and their relationship between oxidative stress, endoplasmic reticulum stress, and apoptosis.miR-223、miR-424、miR-145、miR-200c、miR-139在实验性大鼠慢性胰腺炎模型中的差异表达及其与氧化应激、内质网应激和细胞凋亡的关系。
Iran J Basic Med Sci. 2021 Sep;24(9):1301-1306. doi: 10.22038/ijbms.2021.57664.12823.
氧化还原敏感的丝裂原活化蛋白激酶(MAPK)和Notch3调节成纤维细胞的分化和激活:细胞外信号调节激酶1/2(ERK1/2)的双重作用
Oncotarget. 2016 Jul 12;7(28):43731-43745. doi: 10.18632/oncotarget.9667.
4
Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progression.综合分子分析研究 microRNAs 在胰腺肿瘤生长和进展中的作用。
Lancet. 2015 Feb 26;385 Suppl 1:S37. doi: 10.1016/S0140-6736(15)60352-X.
5
Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways.miR-34c的过表达通过靶向Notch信号通路抑制高糖诱导的足细胞凋亡。
Int J Clin Exp Pathol. 2015 May 1;8(5):4525-34. eCollection 2015.
6
MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.微小RNA-324-5p通过转录后下调ETS1和SP1来对抗细胞外基质降解,从而抑制肝癌细胞侵袭。
PLoS One. 2015 Jul 15;10(7):e0133074. doi: 10.1371/journal.pone.0133074. eCollection 2015.
7
Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.青藤碱通过抑制由IL-4/miR-324-5p/CUEDC2轴介导的NF-κB激活来抑制乳腺癌细胞的侵袭和迁移。
Biochem Biophys Res Commun. 2015 Aug 28;464(3):705-10. doi: 10.1016/j.bbrc.2015.07.004. Epub 2015 Jul 10.
8
Genetic susceptibility factors for alcohol-induced chronic pancreatitis.酒精性慢性胰腺炎的遗传易感性因素。
Pancreatology. 2015 Jul;15(4 Suppl):S23-31. doi: 10.1016/j.pan.2015.05.476. Epub 2015 Jun 18.
9
Potential application of miRNAs as diagnostic and therapeutic tools in chronic pancreatitis.微小RNA作为慢性胰腺炎诊断和治疗工具的潜在应用。
J Cell Mol Med. 2015 Sep;19(9):2049-57. doi: 10.1111/jcmm.12603. Epub 2015 Jul 6.
10
Role of Parathyroid Hormone-Related Protein Signaling in Chronic Pancreatitis.甲状旁腺激素相关蛋白信号通路在慢性胰腺炎中的作用
Cancers (Basel). 2015 Jun 18;7(2):1091-108. doi: 10.3390/cancers7020826.